Prospective Analysis of Spinal Epidural Abscess
ConditionSpinal Epidural Abscess
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFrancis Farhadi
About this trial
This is a prospective study involving all patients treated at the University of Kentucky for spinal epidural abscess over a 2-year period. Based on ongoing referrals of patients with SEA, we expect that 200 patients will be enrolled during this time window. We propose to study all available clinical, pathological, radiological, and socioeconomic data of patients diagnosed with a spinal infection with or without a history of drug abuse over this study period. All patients' charts will be prospectively reviewed starting at the time of presentation for a period of 1 year.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All patient with ICD codes for pyogenic vertebral osteomyelitis, discitis, and spinal epidural abscess will be reviewed for inclusion.
Disqualifiers
Patients unwilling or unable to attend follow up appointments.
Trial population
This study will include all patients, over the age of 18, who will undergo treatment for spinal epidural abscess infections at the University of Kentucky during the study period.
Trial design
Design model
Case-control
Time perspective
Prospective
Treatments tested in this trial
Prospective chart review of subjects diagnosed with spinal epidural abscess
Other interventionCollection and assessment of available clinical, pathological, radiological, and socioeconomic data on subjects presenting with spinal epidural abscess. Standard of care treatment and outcomes for each group will be analyzed.
Treatment groups
200 Participants
are divided into 2 treatment groupsGroup A: Subjects with spinal epidural abscess with a history of drug abuse1 intervention
Group B: Subjects with spinal epidural abscess with no history of drug abuse1 intervention
Trial outcomes
Primary outcomes
1
Correlation between employment status and infection reoccurrence.
Determine the statistical correlation between employment status and infection reoccurrence within 1 year of diagnosis.
Time frame
1 year2
Correlation between income and infection reoccurrence.
Determine the statistical correlation between income and infection reoccurrence within 1 year of diagnosis.
Time frame
1 year3
Correlation between insurer and infection reoccurrence.
Determine the statistical correlation between insurer (private, Medicare/Medicade and uninsured) and infection reoccurrence within 1 year of diagnosis.
Time frame
1 year4
Correlation between living situation and infection reoccurrence.
Determine the statistical correlation between living situation (owns, rents, or homeless) and infection reoccurrence within 1 year of diagnosis.
Time frame
1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Francis Farhadi
Lead sponsor
University of Kentucky
Sponsor institution
Source ClinicalTrials.gov